Let's face it, we've all been rekt in our alt portfolios by this recent BTC rally. However, the year isn't over yet, and there is still some hope. After the fork on 15/17 November, lots of people will be looking for somewhere to stash their free BTC - and hopefully that place will be alts. Also, I believe that a lot of alts are undervalued right now, and have been...
Very near from support in all time down, far away from bullist trend line.
In my opinion Patientory is on heavy support. Parts of moving average will intersect (I hope) and according to RSI and MACD it is good opportunity to buy.
- possible breakout for ATL conference - targets are marked close to resistances - buy zone marked on the orange highlighted area - SET stop losses as needed - trade at your own risk
Trend your best friend. Good potential for long term
- expected to bounce off 0.00009655 support before is shoots back up - possible breakout expected in 12- 36 hours - buy zone marked in orange off the support - set stop losses as necessary - TRADE at your own risk
This is a relatively new coin so it's a risky trade, I won't lie to ya. Broke out of the triangle and touched Gann 3/1, it seems like it has good potential. It's also very unique and the developers/backers behind the coin are active and seem very invested
PTOY looks like it wants to build support at the 23% retracement. Next resistance at the upper end of the red channel - could see PTOY touch 70-80 cents in the days ahead
Hey guys. If you guys have been following then you would have been on some massive gains in the past couple of weeks from PTOY. We bought in all the way down at 5k sats and then again at 7500k sats. We still believe this can go much higher due to the low market cap and the large market it is in. They have a conference coming up soon and we heard they are awaiting...
Looks like the Patientory token is slowly gearing up and closing in on the symmetrical triangle. Healthcare records need protecting, this is one of those projects which is very potential and still in its early market cycle stages.